Preliminary data from an ongoing trial comparing the immune infiltrate of mUM and mCM show that in accordance with the previously mentioned trial, the density of CD3+CD8+, as well as the distance from CD8+ lymphocyte to tumor cell, was similar in both tumor types. This evidence concerns the gene CD8A and neoplasm.